ArticleBMC cancer2025

Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.

Mercedes Salgado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.